The Lynx Group Announces the Addition of Danelle Johnston as Chief Nursing Officer and Senior Director of Strategic Planning & Initiatives

Press Releases published on August 17, 2017 in News & Updates

Cranbury, NJ, August 17, 2017 - The Lynx Group, a global strategic alliance of medical communications and education companies and the official association management and marketing company of the Academy of Oncology Nurse & Patient Navigators (AONN+), is pleased to announce that Danelle Johnston, RN, MSN, BSN, ONN-CG, OCN, CBCN, has joined its team as Chief Nursing Officer and Senior Director of Strategic Planning & Initiatives.

In this role, Johnston will oversee the strategic and operational responsibility of staff, programs, and expansion as well as the execution of AONN+’s mission. Johnston has been involved with AONN+ since its inception in 2009. Most recently, she served as a member of AONN+’s Leadership Council, providing insight and expertise to help guide the Academy’s varied educational activities.

“Danelle’s drive and passion makes her an excellent fit for this new role,” says Lynx Group CEO Brian Tyburski. “She possesses a firm understanding for operational processes and management, clinical and medical content strategy and development, and effective team development—skills that will serve her and the organization well as we continue on our growth trajectory.”

“The opportunity to create custom solutions for Life Science companies is what keeps me driven,” says Johnston. “To be able to provide these services within the confines of a growing company is optimal to providing exceptional, high-quality results for our growing list of clients.”

Johnston, who possesses more than 24 years of industry experience, will leverage her background in clinical and operational management, deep clinical oncology expertise, and strong understanding for industry standards to provide exceptional leadership in this new role.

“The move to offer our growing number of customers and clients strategic consulting services was very natural to the type of work we have been providing to Life Science companies over the years,” says Tyburski. “The delivery of healthcare has undergone a transformation and Life Science companies are demanding strategic thinking with in-depth knowledge of new decision makers. Danelle and her whole team at AONN+ will be there to help them navigate through this continued transformation and deliver exceptional business growth for their respective brands.”

Related Items
AONN+'s ER+ Premenopausal Breast Cancer Journey Pathway Wins PM360 Pharma Choice Award
Press Releases published on February 28, 2024 in News & Updates
Cranbury, NJ (February 28, 2024)—The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to share that PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostic industries, has named AONN+’s estrogen-receptor-positive (ER+) Premenopausal Breast Cancer Journey Pathway, supported by TerSera Therapeutics, as the Pharma Choice Award – Variety Silver Winner.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Selects Sites to Participate in National Acuity Quality Initiative
Press Releases published on October 4, 2023 in News & Updates
CRANBURY, NJ (Oct. 4, 2023) – The Academy of Oncology Nurse & Patient Navigators’ (AONN+) National Navigation Acuity Taskforce is developing a standardized, validated, evidence-based Navigation Acuity Tool for oncology navigation programs. When finalized, the acuity tool is expected to help oncology navigators characterize the intensity of the patient navigation workload, aid in the allocation of resources, and measure the effectiveness of navigation on patient outcomes.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Announces New Leadership Council Members
Press Releases published on August 16, 2023 in News & Updates
CRANBURY, NJ—Each year, the AONN+ Leadership Council strives to bring novel ideas and perspectives to the table through the addition of new members.